Super-TDU is a YAP-TEAD interaction-inhibiting peptide with potential therapeutic applications in cancers characterized by a high YAP/VGLL4 ratio, particularly gastric cancer. It selectively inhibits the growth and colony formation of certain tumor cell lines (e.g., MGC-803, BGC-823, HGC27, HeLa, HCT116, A549, and MCF-7) while showing minimal effects on others (e.g., MKN-45, Jurkat, and Raji). Super-TDU suppresses the expression of YAP-TEAD target genes such as CTGF, CYR61, and CDX2, and demonstrates selective anti-tumor activity in vivo by directly targeting the YAP-TEAD interaction, offering a potentially more targeted approach compared to conventional chemotherapeutics like 5-FU.